BCM
Bayesian Capital Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,087
| Closed | -$307K | – | 665 |
|
|
2024
Q4 | $307K | Buy |
+6,087
| New | +$307K | 0.04% | 481 |
|
|
2024
Q2 | – | Sell |
-27,923
| Closed | -$703K | – | 803 |
|
|
2024
Q1 | $703K | Buy |
+27,923
| New | +$703K | 0.07% | 370 |
|
|
2023
Q4 | – | Sell |
-12,409
| Closed | -$338K | – | 798 |
|
|
2023
Q3 | $338K | Buy |
+12,409
| New | +$338K | 0.04% | 446 |
|
|
2020
Q4 | – | Sell |
-28,057
| Closed | -$488K | – | 487 |
|
|
2020
Q3 | $488K | Buy |
+28,057
| New | +$488K | 0.12% | 231 |
|
|
2020
Q2 | – | Sell |
-19,400
| Closed | -$231K | – | 562 |
|
|
2020
Q1 | $231K | Buy |
19,400
+6,701
| +53% | +$79.8K | 0.05% | 541 |
|
|
2019
Q4 | $154K | Buy |
+12,699
| New | +$154K | 0.03% | 552 |
|
|
2017
Q4 | – | Sell |
-14,700
| Closed | -$284K | – | 577 |
|
|
2017
Q3 | $284K | Buy |
+14,700
| New | +$284K | 0.07% | 376 |
|